Understanding how T cells respond to immune challenges in blood diseases
Official title: COPII dependent regulation of T cell alloimmunity
Funded at Baylor College of Medicine · NIH-10744487 · Data updated 2026-11-12
This study is looking at how T cells, a type of immune cell, respond after blood stem cell transplants, with the goal of finding ways to make these transplants safer and more effective for people with blood disorders.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project start | November 19, 2022 |
| Project end | April 30, 2026 |
| Funding year | 2023 |
| Award (this year) | $621,640 |
| NIH project number | 7R01HL152605-04 |
| Project ID | NIH-10744487 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients undergoing allogeneic hematopoietic cell transplants or those with hematological diseases who may benefit from improved transplant strategies.
✕Less likely to help
Patients with non-hematological conditions or those not undergoing stem cell transplants may not receive any benefit from this research.
What this research studies
This research investigates the role of T cells in immune responses, particularly focusing on how they react to foreign antigens after blood stem cell transplants. The study aims to uncover the molecular mechanisms that drive T cell alloimmunity, which can lead to complications like graft versus host disease (GVHD). By examining the transport of proteins within T cells, the researchers hope to identify new targets that could improve the effectiveness of blood stem cell transplants for patients with hematological diseases. The approach includes using genetically modified mice and human samples to explore these processes.
Why it matters
Potential benefit: If successful, this research could lead to improved therapies for patients undergoing blood stem cell transplants, reducing the risk of complications and enhancing treatment outcomes.
How similar studies have gone: Previous research has shown promise in understanding T cell behavior in similar contexts, but this specific approach focusing on COPII transport mechanisms is relatively novel.
Where this research is happening
-
Baylor College of Medicine
Houston, United States Active
Researchers
- Principal investigator: Reddy, Pavan — Baylor College of Medicine
- Study coordinator: Reddy, Pavan
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.